ManagementInnovative Cell Reprogramming
NuPotential, Inc. is addressing the high-growth cell therapeutics market by developing new systems for evaluating and directing human cell reprogramming and differentiation. Cell reprogramming modifies an existing cell to restore its potential to differentiate into a new cell type, providing a valuable new method for regenerating cells and tissues.
NuPotential will use its novel technologies to address the urgent customer demand for new, renewable cell lines that alleviate the shortage of starting material for cell therapy development. These products will simplify and accelerate cell therapy research, enabling researchers to more quickly and precisely develop regenerative therapies for such afflictions as Alzheimer’s disease, diabetes, stroke, and others.